These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26266963)

  • 21. An Integrated Approach of Fuzzy Linguistic Preference Based AHP and Fuzzy COPRAS for Machine Tool Evaluation.
    Nguyen HT; Md Dawal SZ; Nukman Y; Aoyama H; Case K
    PLoS One; 2015; 10(9):e0133599. PubMed ID: 26368541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dessecting the toxicological profile of polysorbate 80 (PS80): comparative analysis of constituent variability and biological impact using a zebrafish model.
    Wang J; Sun H; Yang H; Yang R; Zhu X; Guo S; Huang Y; Xu Y; Li C; Tu J; Sun C
    Eur J Pharm Sci; 2024 Jul; 198():106796. PubMed ID: 38735400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polysorbate 80 increases the susceptibility to oxidative stress in rat thymocytes.
    Tatsuishi T; Oyama Y; Iwase K; Yamaguchi JY; Kobayashi M; Nishimura Y; Kanada A; Hirama S
    Toxicology; 2005 Feb; 207(1):7-14. PubMed ID: 15590117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity.
    Limaye S; Steele RH; Quin J; Cleland B
    J Allergy Clin Immunol; 2002 Sep; 110(3):530. PubMed ID: 12209107
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk assessment of hybrid rain harvesting system and other small drinking water supply systems by game theory and fuzzy logic modeling.
    Liu B; Huang JJ; McBean E; Li Y
    Sci Total Environ; 2020 Mar; 708():134436. PubMed ID: 31780148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of polyoxyethylated excipients in humans: implications for drug safety and formulation approaches.
    Ten Tije AJ; Loos WJ; Verweij J; Baker SD; Dinh K; Figg WD; Sparreboom A
    Clin Pharmacol Ther; 2003 Nov; 74(5):509-10. PubMed ID: 14586392
    [No Abstract]   [Full Text] [Related]  

  • 27. The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan.
    Chang LC; Kang JJ; Gau CS
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):947-52. PubMed ID: 26387930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Indirect identification of hypersensitivity reaction to etoposide mediated by polysorbate 80].
    Pantín C; Letellez J; Calzas J; Mohedano E
    Farm Hosp; 2018 Jan; 42(1):27-28. PubMed ID: 29306312
    [No Abstract]   [Full Text] [Related]  

  • 29. Tunnel collapse risk assessment based on improved quantitative theory III and EW-AHP coupling weight.
    Li L; Ni B; Zhang S; Qiang Y; Zhang Z; Zhou L; Liu G; Cheng L
    Sci Rep; 2022 Sep; 12(1):16054. PubMed ID: 36163228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin.
    Steele RH; Limaye S; Cleland B; Chow J; Suranyi MG
    Nephrology (Carlton); 2005 Jun; 10(3):317-20. PubMed ID: 15958049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bimodal fuzzy analytic hierarchy process (BFAHP) for coronary heart disease risk assessment.
    Sabahi F
    J Biomed Inform; 2018 Jul; 83():204-216. PubMed ID: 29625186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Local Tolerability to 5 Long-acting Drug Nanosuspensions with Different Stabilizing Excipients, Following a Single Intramuscular Administration in the Rat.
    Chamanza R; Darville N; van Heerden M; De Jonghe S
    Toxicol Pathol; 2018 Jan; 46(1):85-100. PubMed ID: 29096596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An assessment of the ocular safety of inactive excipients following sub-tenon injection in rabbits.
    Younis HS; Shawer M; Palacio K; Gukasyan HJ; Stevens GJ; Evering W
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):206-16. PubMed ID: 18345993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An approach for environmental risk assessment of engineered nanomaterials using Analytical Hierarchy Process (AHP) and fuzzy inference rules.
    Topuz E; van Gestel CA
    Environ Int; 2016; 92-93():334-47. PubMed ID: 27131016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vendor qualification for pharmaceutical excipients--GMP requirements and approach.
    Patel KT; Chotal NP
    Pharmazie; 2010 Nov; 65(11):783-90. PubMed ID: 21155382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):88-95. PubMed ID: 16260028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using a fuzzy comprehensive evaluation method to determine product usability: A test case.
    Zhou R; Chan AH
    Work; 2017; 56(1):21-29. PubMed ID: 28035942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harmful excipients in medicines for neonates in Spain.
    Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
    Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety of pharmaceutical excipients.
    Pifferi G; Restani P
    Farmaco; 2003 Aug; 58(8):541-50. PubMed ID: 12875883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using a fuzzy comprehensive evaluation method to determine product usability: A proposed theoretical framework.
    Zhou R; Chan AH
    Work; 2017; 56(1):9-19. PubMed ID: 28035943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.